《当前药理学观点》(Current Opinion In Pharmacology)是一本以医学-药学综合研究为特色的国际期刊。该刊由Elsevier BV出版商创刊于2001年,刊期Bimonthly。该刊已被国际重要权威数据库SCIE收录。期刊聚焦医学-药学领域的重点研究和前沿进展,及时刊载和报道该领域的研究成果,致力于成为该领域同行进行快速学术交流的信息窗口...
Current Opinion In Pharmacology创刊于2001年,由Elsevier BV出版商出版,收稿方向涵盖医学 - 药学全领域,此刊是中等级别的SCI期刊,所以过审相对来讲不是特别难,但是该刊专业认可度不错,仍然是一本值得选择的SCI期刊 。平均审稿速度 偏慢,4-8周 ,影响因子指数4,该期刊近期没有被列入国际期刊预警名单,广大学者值得...
Current Opinion in Pharmacology (COPHAR)publishes authoritative, comprehensive, and systematic reviews. COPHAR helps specialists keep up to date with a clear and readable synthesis on current advances in pharmacology and drug discovery. Expert authors annotate the most interesting papers from the … ...
Current Opinion in Pharmacology (COPHAR)publishes authoritative, comprehensive, and systematic reviews. COPHAR helps specialists keep up to date with a clear and readable synthesis on current advances in pharmacology and drug discovery. Expert authors annotate the most interesting papers from the … ...
当前药理学观点(Current Opinion In Pharmacology)是一本由Elsevier BV出版的一本医学-药学学术刊物,主要报道医学-药学相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于2001年,出版周期Bimonthly。2021-2022年最新版WOS分区等级:Q1,2023年发布的影响因子为4,CiteScore指数8.8,SJR指数1.203。本刊非开放获取期刊。
《CURRENT OPINION IN PHARMACOLOGY》 期刊名缩写:CURR OPIN PHARMACOL 22年影响因子:4.768 issn:1471-4892 eIssn:1471-4973 类别: 医学工程技术 学科与分区: 药理学和药理学(PHARMACOLOGY & PHARMACY) - SCIE(Q2) 出版国家或地区:ENGLAND 出版周期:Bimonthly 出版年份:2001 年文章数:102 是否OA开放访问:No ...
COPHAR is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Pharmacology and Drug Discovery (CRPHAR) . COPHAR divides the subject of pharmacology into themed sections, each of which is...
COPHAR is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Pharmacology and Drug Discovery (CRPHAR) . COPHAR divides the subject of pharmacology into themed sections, each of which is...
大类:Pharmacology, Toxicology and Pharmaceutics小类:PharmacologyQ154 / 313 82% 大类:Pharmacology, Toxicology and Pharmaceutics小类:Drug DiscoveryQ130 / 157 81% 名词解释: CiteScore:由Elsevier集团开发,类似影响因子用来评估杂志期刊学术影响力的一个指标。CiteScore采用了四年区间来计算每个期刊的学术引用。Cite...
Read the latest articles of Current Opinion in Pharmacology at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature